The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / From AIDS to Zika: ‘What’s next?’ asked Dr. Anthony Fauci in keynote address at the 2017 ACR/ARHP Annual Meeting

From AIDS to Zika: ‘What’s next?’ asked Dr. Anthony Fauci in keynote address at the 2017 ACR/ARHP Annual Meeting

November 5, 2017 • By Keri Losavio

  • Tweet
  • Email
Print-Friendly Version / Save PDF

SAN DIEGO—The 2017 ACR/ARHP Annual Meeting kicked off on Nov. 4 with a rousing presentation by Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID). A terrorist attack on U.S. soil, hurricane, cyberattack and pandemic were the four scenarios played out in late 2016, when NIAID conducted a tabletop exercise for the newly elected president’s incoming cabinet.

You Might Also Like
  • 2017 ACR/ARHP Annual Meeting Highlights
  • 2017 in Review: Key Findings in Basic Science Highlighted at the ACR/ARHP Annual Meeting
  • RISE Data Use to Be Highlighted at 2017 ACR/ARHP Annual Meeting
Explore this issue
December 2017
Also by this Author
  • 2015 ACR Workforce Study Survey Now Open

In this first year of Donald Trump’s presidency, three of these four potential disasters have already occurred: We’ve had a terrorist attack in Las Vegas. Hurricanes Harvey, Irma and Maria wreaked untold damage in Texas, Florida and Puerto Rico. And the extent of Russia’s cyberattacks and interference in the election is still being uncovered. “That leaves pandemic,” said Dr. Fauci.

Anthony S. Fauci, MD (NIAID)

Anthony S. Fauci, MD (NIAID)

In Dr. Fauci’s keynote address, Emerging & Reemerging Infectious Diseases: From AIDS to Zika, he recapped what the world has learned in the past 30-odd years from our experience with infectious diseases, such as HIV/AIDS, influenza, SARS, West Nile, Ebola and Zika.

Dr. Fauci was appointed director of NIAID in 1984. He oversees an extensive research portfolio of basic and applied research to prevent, diagnose and treat established infectious diseases. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. The NIAID budget for fiscal year 2017 is approximately $4.9 billion.

Dr. Fauci has advised five presidents and the U.S. Department of Health and Human Services on HIV/AIDS and many other domestic and global health issues. He was one of the principal architects of the President’s Emergency Plan for AIDS Relief, a program that has saved millions of lives throughout the developing world.

AIDS/HIV
The AIDS epidemic was the topic of Dr. Fauci’s first appearance before Congress following his appointment to NIAID by President Ronald Reagan. He said, “… because we do not know the cause of this syndrome, any assumption that the syndrome will remain restricted to a particular segment of our society is truly an assumption without scientific basis.”

As of 2016, globally, 76.1 million people have been infected with HIV, and 35 million people have died from AIDS-related illnesses—1 million died in 2016 alone. But that’s only part of the picture. 36.7 million people are living with HIV. That’s right, living with the disease. Funding for research made the difference.

In fact, following diagnosis in today’s world, Dr. Fauci can tell patients that they have a life expectancy of 53 years. When Dr. Fauci was first reporting on AIDS/HIV to Congress, the cause was unknown, patients were diagnosed late into their illness and they had a life expectancy of 8 to 15 months. Today, if you assume a patient is diagnosed in their 20s, they have a near-normal life expectancy. That progress led Dr. Fauci to state an important lesson he’s learned in his career: “When we put resources into a disease, we can get results.”

Pages: 1 2 3 Single Page

Filed Under: Meeting Reports Tagged With: 2017 ACR/ARHP Annual MeetingIssue: December 2017

You Might Also Like:
  • 2017 ACR/ARHP Annual Meeting Highlights
  • 2017 in Review: Key Findings in Basic Science Highlighted at the ACR/ARHP Annual Meeting
  • RISE Data Use to Be Highlighted at 2017 ACR/ARHP Annual Meeting
  • Refocus Your Practice with Invigorating Sessions at 2017 ACR/ARHP Annual Meeting

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

American College of Rheumatology

Visit the official web site for the American College of Rheumatology.

Visit the ACR »

ACR Meeting Abstracts

Browse and search abstracts from the ACR Annual Meetings going back to 2012.

Visit the ACR Meeting Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2018 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.